Metraipolis › archive › dc_d83ed282bb9c
Empagliflozin Improves Post-Infarct Heart Failure Through Fibroblast Growth Factor-21 and Ketone Body Oxidation Pathway — Europe PMC PMID:42645205
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42645205
- DOI
- 10.3390/cells15161478
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T03:13:16.717Z
- SHA-256 of the archived text
61ba3f3a07f6500440ca3c67bdf024fd880dc4bd776e70d4a550fcc6f1322bb5- Stable URL of this page
https://metraipolis.com/documento/dc_d83ed282bb9c
How to cite
Empagliflozin Improves Post-Infarct Heart Failure Through Fibroblast Growth Factor-21 and Ketone Body Oxidation Pathway — Europe PMC PMID:42645205 — Europe PMC (en), https://europepmc.org/article/MED/42645205 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d83ed282bb9c (Metraipolis archive dc_d83ed282bb9c, sha256 61ba3f3a07f6500440ca3c67bdf024fd880dc4bd776e70d4a550fcc6f1322bb5)
BibTeX
@misc{dcd83ed282bb9c,
title = {Empagliflozin Improves Post-Infarct Heart Failure Through Fibroblast Growth Factor-21 and Ketone Body Oxidation Pathway — Europe PMC PMID:42645205},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42645205},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d83ed282bb9c; sha256 61ba3f3a07f6500440ca3c67bdf024fd880dc4bd776e70d4a550fcc6f1322bb5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645205. Agents can read the archived copy with the MCP tool read_document.